Sex: F
Vaccine: RAB, UNK
Symptoms: Groin pain, Headache, Lymphadenopathy, Nausea, Pain
Clinical narrative: Pain when walking; The patient's groin area in particular was a little painful on right side and felt on the left side; The patient had swollen glands, that were actually a little painful; Headache; Nausea; Discomfort; Case reference number US-BN-2024-000678 is a spontaneous case report initially received from a consumer (reference number USBAV24-0564) on 25-Mar-2024 and concerns a female patient of unspecified age.  The patient's current conditions included breast cancer and immunodeficiency, reported as immunocompromised.  The patient's concomitant medication details were not provided.  On an unspecified date the patient was bitten by bat.  On 18-Mar-2024, unknown amount of time after animal exposure, the patient received first dose of RabAvert (batch number: BNARBB1Q1B, although as reported unknown if Q or zero), administered intramuscularly at unknown dose or site of administration, and with co-suspect immunoglobulin (brand name unknown), at an unknown dose, route or site of administration, both for bat bite post exposure.  On 21-Mar-2024, unknown amount of time after animal exposure the patient received second dose of RabAvert (batch number: BNARBB1Q1B, although as reported unknown if Q or zero), administered intramuscularly at unknown dose or site of administration.  On 25-Mar-2024, for unknown amount of time after animal exposure the patient received third dose of RabAvert (batch number: BNARBB1Q1B, although as reported unknown if Q or zero), administered intramuscularly at unknown dose or site of administration.  On unspecified date, unknown amount of time after receiving RabAvert, the patient developed swollen lymph glands, reported as little painful, painful groin area on right side and felt on the left, discomfort, pain when walking, headaches and nausea.  At the time of the initial report, the outcome for the events of pain when walking, groin pain, discomfort, painful lymphadenopathy, headache and nausea was unknown.   The reporter assessed that the events of pain when walking, groin pain, discomfort, painful lymphadenopathy, headache and nausea as non-serious and possibly related to either RabAvert or immunoglobulin.   No further information was provided.; Reporter's Comments: A female patient of unspecified age received three doses of RabAvert, administered intramuscularly at unknown dose or site of administration. On unspecified date, unknown amount of time after receiving RabAvert, the patient developed swollen lymph glands, reported as little painful, painful groin area on right side and felt on the left, discomfort, pain when walking, headaches and nausea. Pain and groin pain are unlisted/unexpected, whilst lymphadenopathy, nausea and headache are listed/expected for Rabipur according to summary. Discomfort is listed per company convention as a non-specific event. Due to lack of information on alternative etiology, the evaluation did not find enough evidence at this point to exclude at least a contributory role of RabAvert in development of reported events, therefore the causality is assessed conservatively as related to RabAvert. The case is non-serious.; Sender's Comments: A female patient of unspecified age received three doses of RabAvert, administered intramuscularly at unknown dose or site of administration. On unspecified date, unknown amount of time after receiving RabAvert, the patient developed swollen lymph glands, reported as little painful, painful groin area on right side and felt on the left, discomfort, pain when walking, headaches and nausea. Pain and groin pain are unlisted/unexpected, whilst lymphadenopathy, nausea and headache are listed/expected for Rabipur according to summary. Discomfort is listed per company convention as a non-specific event. Due to lack of information on alternative etiology, the evaluation did not find enough evidence at this point to exclude at least a contributory role of RabAvert in development of reported events, therefore the causality is assessed conservatively as related to RabAvert. The case is non-serious.